Omega Diagnostics Group PLC
ODX.L · LSE
3/31/2023 | 3/31/2022 | 3/31/2021 | 3/31/2020 | |
|---|---|---|---|---|
| Revenue | £7,546 | £8,539 | £8,735 | £9,819 |
| % Growth | -11.6% | -2.2% | -11% | – |
| Cost of Goods Sold | £4,001 | £3,437 | £4,276 | £3,525 |
| Gross Profit | £3,545 | £5,102 | £4,459 | £6,294 |
| % Margin | 47% | 59.7% | 51% | 64.1% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £4,755 | £4,438 | £6,603 | £5,375 |
| SG&A Expenses | £6,285 | £5,694 | £8,082 | £6,865 |
| Sales & Mktg Exp. | £1,530 | £1,256 | £1,480 | £1,490 |
| Other Operating Expenses | £0 | £0 | -£302 | -£258 |
| Operating Expenses | £6,260 | £5,694 | £7,781 | £6,607 |
| Operating Income | -£2,715 | -£592 | -£3,322 | -£313 |
| % Margin | -36% | -6.9% | -38% | -3.2% |
| Other Income/Exp. Net | -£537 | -£358 | -£218 | -£7,984 |
| Pre-Tax Income | -£3,252 | -£950 | -£3,540 | -£8,298 |
| Tax Expense | -£80 | £459 | -£1,436 | -£1,469 |
| Net Income | -£3,860 | -£1,409 | -£2,104 | -£6,828 |
| % Margin | -51.2% | -16.5% | -24.1% | -69.5% |
| EPS | -1.67 | -0.008 | -0.012 | -0.048 |
| % Growth | -22,166.7% | 37% | 75.3% | – |
| EPS Diluted | -0.017 | -0.008 | -0.012 | -0.048 |
| Weighted Avg Shares Out | 2,313 | 182,638 | 171,689 | 142,050 |
| Weighted Avg Shares Out Dil | 231,839 | 186,998 | 177,104 | 142,096 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £0 | £0 | £0 |
| Interest Expense | £13 | £21 | £218 | £252 |
| Depreciation & Amortization | £591 | £1,289 | £886 | £1,152 |
| EBITDA | -£2,648 | £360 | -£2,436 | -£6,894 |
| % Margin | -35.1% | 4.2% | -27.9% | -70.2% |